CADTH Canadian drug expert committee recommendation. Latanoprost (Monoprost -- Laboratoires Thea) : indication : glaucoma and ocular hypertension.

CADTH Canadian drug expert committee recommendation. indication : glaucoma and ocular hypertension. Latanoprost (Monoprost -- Laboratoires Thea) :

The CADTH Canadian Drug Expert Committee (CDEC) recommends that preservative-free latanoprost 50 μg/mL ophthalmic solution (Monoprost) be reimbursed for the reduction of intraocular pressure in patients with open-angle glaucoma or ocular hypertension, if the following condition is met: The drug plan...

Full description

Saved in:
Bibliographic Details
Online Access: http://www.ncbi.nlm.nih.gov/books/NBK532704/
Full text
Corporate Author: CADTH Canadian Drug Expert Committee (Author)
Format: Electronic eBook
Language:English
Published: Ottawa (ON) : Canadian Agency for Drugs and Technologies in Health, 2018
Edition:Version 1.0.
Series:Common drug review clinical review report.
Subjects:
Glaucoma > drug therapy.
Ocular Hypertension > drug therapy.
Latanoprost > therapeutic use.
Latanoprost > economics.
Insurance, Health, Reimbursement > economics.
Drug Costs.
Cost-Benefit Analysis.
Canada.

Internet

http://www.ncbi.nlm.nih.gov/books/NBK532704/
Full text

Similar Items